ARDT Ardent Health, Inc.
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 1756655 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.0%
TTM net income YoY-28.7%
TTM EPS YoY-30.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin2.3%
FCF margin—
EBITDA margin—
Returns
ROE11.1%
ROA2.8%
ROIC (approx.)—
Asset turnover1.23x
Leverage & solvency
Liabilities / assets66.7%
Debt / equity0.79x
Current ratio2.13x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.30x
Accruals ratio-6.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.62B | $1.62B | $1.60B | $1.61B | $1.58B | $1.65B | $1.50B | $1.61B |
| SG&A expense | $42.40M | $61.20M | $48.60M | $36.80M | $36.50M | $32.60M | $34.90M | $36.70M |
| Pretax income | $81.03M | $43.20M | $74.59M | $92.37M | -$2.20M | $121.99M | $74.20M | $167.25M |
| Income tax | $17.64M | $8.51M | $16.10M | $18.11M | -$3.41M | $26.29M | $15.23M | $26.36M |
| Net income | $44.52M | $16.90M | $39.85M | $44.96M | -$23.48M | $72.95M | $41.38M | $114.20M |
| EPS (basic) | 0.32 | 0.12 | 0.28 | — | -0.17 | 0.52 | 0.30 | — |
| EPS (diluted) | 0.31 | 0.12 | 0.28 | — | -0.17 | 0.52 | 0.29 | — |
| Weighted avg. shares (diluted) | 141.70M | 143.05M | 141.78M | — | 141.23M | 141.52M | 140.70M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $766.24M | $724.48M | $609.69M | $709.60M | $609.44M | $540.63M | $495.04M | $556.78M |
| Receivables | $661.85M | $695.95M | $685.99M | $686.10M | $729.41M | $758.64M | $776.52M | $743.03M |
| Inventory | $110.10M | $116.02M | $119.84M | $118.59M | $121.59M | $118.40M | $120.36M | $115.09M |
| Current assets | $2.17B | $2.05B | $2.02B | $2.06B | $1.96B | $1.88B | $1.76B | $1.83B |
| PP&E, net | $899.77M | $920.04M | $922.81M | $935.77M | $887.98M | $870.38M | $856.52M | $861.90M |
| Goodwill | $861.86M | $879.26M | $879.26M | $879.45M | $877.51M | $877.68M | $876.59M | $852.08M |
| Intangibles | — | — | — | $12.40M | — | — | — | — |
| Total assets | $5.35B | $5.28B | $5.25B | $5.29B | $5.15B | $5.03B | $4.91B | $4.96B |
| Current liabilities | $1.02B | $976.32M | $951.48M | $1.05B | $943.15M | $880.87M | $830.14M | $945.42M |
| Short-term debt | $28.76M | $28.57M | $37.63M | $23.44M | $19.34M | $19.33M | $17.76M | $9.23M |
| Long-term debt | $1.07B | $1.07B | $1.07B | $1.08B | $1.09B | $1.09B | $1.09B | $1.09B |
| Total debt | $1.10B | $1.10B | $1.11B | $1.10B | $1.11B | $1.11B | $1.11B | $1.10B |
| Total liabilities | $3.57B | $3.54B | $3.52B | $3.61B | $3.52B | $3.38B | $3.35B | $3.43B |
| Shareholders' equity | $1.40B | $1.35B | $1.34B | $1.29B | $1.24B | $1.25B | $1.18B | $1.13B |
| Net debt | $332.21M | $377.31M | $500.71M | $389.62M | $496.92M | $569.09M | $613.26M | $538.27M |
| Shares outstanding | 140.93M | 141.91M | 143.13M | 142.86M | 143.17M | 143.10M | 143.04M | 142.75M |
| Cash flow statement | ||||||||
| Operating cash flow | $121.93M | $196.74M | -$60.22M | $223.44M | $154.37M | $117.49M | -$24.79M | $119.57M |
| Investing cash flow | -$40.14M | -$39.18M | -$27.90M | -$86.23M | -$58.63M | -$46.25M | -$23.12M | -$105.44M |
| Financing cash flow | -$40.03M | -$42.77M | -$11.79M | -$37.05M | -$26.93M | -$25.66M | -$13.83M | -$20.48M |
| Depreciation & amortization | $41.06M | $41.34M | $42.99M | $41.04M | $39.16M | $39.31M | $36.20M | $37.85M |
| Share buybacks | $10.98M | — | — | — | $0 | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 15 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.